Zhou M, Cole P
Nat Rev Drug Discov. 2024; 24(2):112-133.
PMID: 39572658
PMC: 11798720.
DOI: 10.1038/s41573-024-01080-6.
Zhang S, Roeder R
Nat Struct Mol Biol. 2024; 32(1):98-112.
PMID: 39251822
DOI: 10.1038/s41594-024-01384-6.
Mondal A, Singh B, Felkner R, De Falco A, Swapna G, Montelione G
Angew Chem Int Ed Engl. 2024; 63(24):e202405767.
PMID: 38588243
PMC: 11544546.
DOI: 10.1002/anie.202405767.
Huang Q, Fan D, Zheng Z, Ran T, Bai A, Xiao R
J Med Chem. 2024; 67(8):6658-6672.
PMID: 38569135
PMC: 11056977.
DOI: 10.1021/acs.jmedchem.4c00141.
Mondal A, Singh B, Felkner R, De Falco A, Swapna G, Montelione G
bioRxiv. 2024; .
PMID: 38328039
PMC: 10849530.
DOI: 10.1101/2024.01.20.576374.
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy.
Wang Z, Zhang Z, Wu Y, Pi Y, Lou S, Liu T
Signal Transduct Target Ther. 2023; 8(1):420.
PMID: 37926722
PMC: 10625992.
DOI: 10.1038/s41392-023-01647-6.
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.
To K, Xing E, Larue R, Li P
Molecules. 2023; 28(7).
PMID: 37049806
PMC: 10096006.
DOI: 10.3390/molecules28073043.
Structure Determination of Challenging Protein-Peptide Complexes Combining NMR Chemical Shift Data and Molecular Dynamics Simulations.
Mondal A, Swapna G, Lopez M, Klang L, Hao J, Ma L
J Chem Inf Model. 2023; 63(7):2058-2072.
PMID: 36988562
PMC: 10150588.
DOI: 10.1021/acs.jcim.2c01595.
Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy.
Gargano D, Segatto M, Di Bartolomeo S
Int J Mol Sci. 2023; 24(6).
PMID: 36982740
PMC: 10055343.
DOI: 10.3390/ijms24065665.
Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation.
Martella N, Pensabene D, Varone M, Colardo M, Petraroia M, Sergio W
Biomedicines. 2023; 11(3).
PMID: 36979729
PMC: 10045827.
DOI: 10.3390/biomedicines11030750.
1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains.
Jiang J, Zhao P, Sigua L, Chan A, Schonbrunn E, Qi J
Arch Pharm (Weinheim). 2022; 355(11):e2200288.
PMID: 35941525
PMC: 9633406.
DOI: 10.1002/ardp.202200288.
A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles.
Ali H, Li Y, Bilal A, Qin T, Yuan Z, Zhao W
Front Pharmacol. 2022; 13:818891.
PMID: 35401196
PMC: 8990909.
DOI: 10.3389/fphar.2022.818891.
A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization.
Dilworth D, Hanley R, Ferreira de Freitas R, Allali-Hassani A, Zhou M, Mehta N
Nat Chem Biol. 2021; 18(1):56-63.
PMID: 34782742
PMC: 9189931.
DOI: 10.1038/s41589-021-00898-0.
BET Proteins as Attractive Targets for Cancer Therapeutics.
Sarnik J, Poplawski T, Tokarz P
Int J Mol Sci. 2021; 22(20).
PMID: 34681760
PMC: 8538173.
DOI: 10.3390/ijms222011102.
Development of Murine Leukemia Virus Integrase-Derived Peptides That Bind Brd4 Extra-Terminal Domain as Candidates for Suppression of Acute Myeloid Leukemia.
Xing E, Surendranathan N, Kong X, Cyberski N, Garcia J, Cheng X
ACS Pharmacol Transl Sci. 2021; 4(5):1628-1638.
PMID: 34661079
PMC: 8506603.
DOI: 10.1021/acsptsci.1c00159.
BRD4 orchestrates genome folding to promote neural crest differentiation.
Linares-Saldana R, Kim W, Bolar N, Zhang H, Koch-Bojalad B, Yoon S
Nat Genet. 2021; 53(10):1480-1492.
PMID: 34611363
PMC: 8500624.
DOI: 10.1038/s41588-021-00934-8.
The Functions of BET Proteins in Gene Transcription of Biology and Diseases.
Cheung K, Kim C, Zhou M
Front Mol Biosci. 2021; 8:728777.
PMID: 34540900
PMC: 8446420.
DOI: 10.3389/fmolb.2021.728777.
Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase.
Rathert P
Life (Basel). 2021; 11(8).
PMID: 34440470
PMC: 8398374.
DOI: 10.3390/life11080726.
A common binding motif in the ET domain of BRD3 forms polymorphic structural interfaces with host and viral proteins.
Aiyer S, Swapna G, Ma L, Liu G, Hao J, Chalmers G
Structure. 2021; 29(8):886-898.e6.
PMID: 33592170
PMC: 8349776.
DOI: 10.1016/j.str.2021.01.010.
Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Yuan G, Flores N, Hausmann S, Lofgren S, Kharchenko V, Angulo-Ibanez M
Nature. 2021; 590(7846):504-508.
PMID: 33536620
PMC: 7895461.
DOI: 10.1038/s41586-020-03170-y.